Roche and rheumatoid arthritis

Despite advances in treatment, for people living with rheumatoid arthritis there remains a significant unmet medical need. Roche is committed to helping people with rheumatoid arthritis by developing therapies that help patients to control the distressing symptoms of the disease, to prevent progressive joint damage and ultimately to achieve remission.

Company overview

Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people’s health and quality of life.